Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects (MYSTICOL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2014 by US WorldMeds LLC
Information provided by (Responsible Party):
US WorldMeds LLC Identifier:
First received: November 14, 2013
Last updated: October 13, 2014
Last verified: October 2014